92 related articles for article (PubMed ID: 24919269)
21. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
22. Comparison of morbidity, 30-day mortality, and long-term survival after pneumonectomy and sleeve lobectomy for non-small cell lung carcinoma.
Ludwig C; Stoelben E; Olschewski M; Hasse J
Ann Thorac Surg; 2005 Mar; 79(3):968-73. PubMed ID: 15734415
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathologic study of resected, peripheral, small-sized, non-small cell lung cancer tumors of 2 cm or less in diameter: pleural invasion and increase of serum carcinoembryonic antigen level as predictors of nodal involvement.
Inoue M; Minami M; Shiono H; Sawabata N; Ideguchi K; Okumura M
J Thorac Cardiovasc Surg; 2006 May; 131(5):988-93. PubMed ID: 16678580
[TBL] [Abstract][Full Text] [Related]
24. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
Kim YT; Kang CH; Sung SW; Kim JH
Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
[TBL] [Abstract][Full Text] [Related]
25. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
26. [Mediastinal lymph node dissection in left lung cancer].
Morishita K; Kusajima K; Tanaka H; Kuroki M; Komatsu S
Kyobu Geka; 1994 Jan; 47(1):24-7. PubMed ID: 8277627
[TBL] [Abstract][Full Text] [Related]
27. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
[TBL] [Abstract][Full Text] [Related]
28. Evolution of surgical outcomes for nonsmall cell lung cancer: time trends in 1465 consecutive patients undergoing complete resection.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
Ann Thorac Surg; 2004 Jun; 77(6):1926-30; discussion 1931. PubMed ID: 15172237
[TBL] [Abstract][Full Text] [Related]
29. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
30. Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.
Nentwich MF; Bohn BA; Uzunoglu FG; Reeh M; Quaas A; Grob TJ; Perez D; Kutup A; Bockhorn M; Izbicki JR; Vashist YK
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):781-7. PubMed ID: 23778087
[TBL] [Abstract][Full Text] [Related]
31. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.
Yildizeli B; Fadel E; Mussot S; Fabre D; Chataigner O; Dartevelle PG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):95-102. PubMed ID: 17126556
[TBL] [Abstract][Full Text] [Related]
32. [Probability of leaving cancer tissue unresected by limited operation in patients with peripheral, stage I non-small cell lung cancer].
Hosokawa Y; Matsuge S; Yamazaki S; Satoh K; Yamakawa S; Hatakeyama H; Kamada H; Ighigooka M; Murakami Y
Kyobu Geka; 1998 Jan; 51(1):27-31. PubMed ID: 9455066
[TBL] [Abstract][Full Text] [Related]
33. Which patients should be operated on after induction chemotherapy for N2 non-small cell lung cancer? Analysis of a 7-year experience in 175 patients.
Stefani A; Alifano M; Bobbio A; Grigoroiu M; Jouni R; Magdeleinat P; Regnard JF
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):356-63. PubMed ID: 20381815
[TBL] [Abstract][Full Text] [Related]
34. The present status of surgery for lung cancer.
Lacquet LK
Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
[TBL] [Abstract][Full Text] [Related]
35. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
36. Less is more… (more or less…).
Murthy SC
J Thorac Cardiovasc Surg; 2011 Mar; 141(3):670-2. PubMed ID: 21335124
[No Abstract] [Full Text] [Related]
37. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic analysis of curative surgery for stage IIIA-N2 non-small cell lung cancer].
Liu JW; Li J; Lin G; Shang XQ
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):50-3. PubMed ID: 23648301
[TBL] [Abstract][Full Text] [Related]
39. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
